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Effectiveness of Long-Acting Reversible
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Christina Buckel, M.S.W., Tessa Madden, M.D., M.P.H., Jenifer E. Allsworth, Ph.D.,
and Gina M. Secura, Ph.D., M.P.H.
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The rate of unintended pregnancy in the United States is much higher than in
other developed nations. Approximately half of unintended pregnancies are due to
contraceptive failure, largely owing to inconsistent or incorrect use.
METHODS

We designed a large prospective cohort study to promote the use of long-acting
reversible contraceptive methods as a means of reducing unintended pregnancies in
our region. Participants were provided with reversible contraception of their choice
at no cost. We compared the rate of failure of long-acting reversible contraception
(intrauterine devices [IUDs] and implants) with other commonly prescribed contraceptive methods (oral contraceptive pills, transdermal patch, contraceptive vaginal
ring, and depot medroxyprogesterone acetate [DMPA] injection) in the overall cohort and in groups stratified according to age (less than 21 years of age vs. 21 years
or older).
RESULTS

Among the 7486 participants included in this analysis, we identified 334 unintended pregnancies. The contraceptive failure rate among participants using pills,
patch, or ring was 4.55 per 100 participant-years, as compared with 0.27 among
participants using long-acting reversible contraception (hazard ratio after adjustment for age, educational level, and history with respect to unintended pregnancy,
21.8; 95% confidence interval, 13.7 to 34.9). Among participants who used pills,
patch, or ring, those who were less than 21 years of age had a risk of unintended
pregnancy that was almost twice as high as the risk among older participants.
Rates of unintended pregnancy were similarly low among participants using DMPA
injection and those using an IUD or implant, regardless of age.
CONCLUSIONS

The effectiveness of long-acting reversible contraception is superior to that of contraceptive pills, patch, or ring and is not altered in adolescents and young women.
(Funded by the Susan Thompson Buffet Foundation.)
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nintended pregnancy is a major
problem in the United States. Approximately 3 million pregnancies per year —
50% of all pregnancies — are unintended, and
this rate is significantly higher than that in other
developed countries.1 Unintended pregnancy in
the United States results in 1.2 million abortions
per year,2 has negative effects on women’s health
and education and the health of newborns, and
imposes a considerable personal burden as well
as a financial burden on families and society.3
Approximately half of unintended pregnancies
result from contraceptive failure, usually owing
to incorrect or inconsistent use of contraception,
and the remainder are due to nonuse.4-6
The most commonly used contraceptive
method in the United States is the oral contraceptive pill.7 Because the pill requires daily compliance, failure rates calculated on the basis of
“perfect use” differ from real-world failure rates
calculated on the basis of typical use. Annual
failure rates with typical use of oral contraceptive pills are estimated at 9% for the general
population, 13% for teenagers, and 30% or
higher for some high-risk subgroups.4,8 Prior
estimates of the failure rates with typical oralcontraceptive use have relied on retrospective
survey data, primarily from the National Survey
of Family Growth.9
Long-acting reversible contraceptive methods,
including intrauterine devices (IUDs) and subdermal implants, are not user-dependent and
have very low failure rates (less than 1%), which
rival those with sterilization.9 Despite their
proven safety in women and adolescents of all
ages,10,11 IUDs are used by only 5.5% of women
who use contraception in the United States.7
Other developed countries, such as the United
Kingdom and France, where IUDs are used more
frequently, have rates of unintended pregnancy
that are lower than those in the United States.12
Prospective data on contraceptive failure from
a large number of women in the United States
are limited. We analyzed data from a cohort of
participants at risk for unintended pregnancy,
who received contraceptive counseling and free
contraception, to compare the rate of failure of
long-acting reversible contraception (IUDs and
implants) with the failure rates for other commonly prescribed contraceptive methods (pills,
transdermal patch, vaginal ring, and depot medroxyprogesterone acetate [DMPA] injection).

n engl j med 366;21

ME THODS
STUDY ENROLLMENT

The Contraceptive CHOICE Project is a prospective cohort study with the primary goal of promoting the use of long-acting reversible contraceptive methods as a means of reducing
unintended pregnancies.13 From August 2007
through September 2011, we enrolled 9256 participants at risk for unintended pregnancy. All
participants chose a contraceptive method and
received it at no cost. Study participants were a
convenience sample of women and adolescents in
the St. Louis region, recruited by means of referrals from medical providers, newspaper reports,
study flyers, and word of mouth.
The study protocol was approved by the local
institutional review board before recruitment was
initiated. All participants provided written informed consent.
Eligible participants were 14 to 45 years of age,
were not currently using a contraceptive method
or were willing to switch to a new reversible contraceptive, had no desire for pregnancy for at least
the next 12 months, were sexually active or were
planning to become sexually active with a male
partner during the next 6 months, resided in the
St. Louis region, and spoke English or Spanish.
Persons were excluded if they had undergone a
hysterectomy or sterilization procedure.
STUDY DESIGN

Before enrollment in the study, all potential participants were read a standardized script regarding long-acting reversible contraceptive methods
that stated that the two IUDs and the subdermal
implant were the most effective methods of contraception (see the Supplementary Appendix, available with the full text of this article at NEJM.org).
If they were eligible for enrollment, participants
received contraceptive counseling regarding all
reversible contraceptive methods, including their
effectiveness, side effects, risks, and benefits. Each
participant was then provided with a reversible
contraceptive method of her choice at no cost for
3 years (first 5090 participants) or 2 years (remainder of cohort). Participants were permitted
to discontinue or switch methods as many times
as desired during the follow-up period. A comprehensive baseline interview was performed, and
participants were screened for sexually transmitted infections.
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Participants were followed prospectively, with
telephone interviews at 3 and 6 months and every 6 months thereafter for the duration of follow-up. Participants received a $10 gift card for
every completed follow-up interview. In the baseline and follow-up interviews, we collected comprehensive information on demographic characteristics and reproductive history.
This analysis includes the first 7486 participants who used an IUD, implant, DMPA injection,
pills, patch, or ring during the study. Periods of
condom use or other contraceptive method use
(e.g., diaphragm or natural family planning) were
excluded from the analysis of contraceptive failure. At each survey, participants were asked about
missed menses and possible pregnancy. Any participant who thought she might be pregnant was
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asked to come in for urine pregnancy testing. A
pregnancy log was used to record all pregnancies.
Participants who had a pregnancy were asked if it
was intended and what contraceptive method (if
any) they were using at the time of conception.
The conception date was estimated from the date
of the last menstrual period or from the gestational-age assessment on ultrasonography. Contraceptive-method failure was defined as conception that occurred during a period when the
contraceptive method was used. If the participant
stated that she had stopped using the method,
this was listed as “no method” and was not considered a contraceptive-method failure. We excluded conception that occurred after a participant stopped using a method owing to a desire to
conceive (intended pregnancy).

Table 1. Characteristics of Study Participants, According to Contraceptive Method Chosen at Baseline.*
PPR
(N = 1527)

DMPA
(N = 176)

LARC
(N = 5781)

23.9±4.7

23.9±5.5

25.5±6.0

Black

639/1519 (42.1)

122/176 (69.3)

2846/5750 (49.5)

White

752/1519 (49.5)

43/176 (24.4)

2471/5750 (43.0)

Other

128/1519 (8.4)

11/176 (6.3)

433/5750 (7.5)

High school or less

364/1527 (23.8)

90/175 (51.4)

2065/5778 (35.7)

Some college

684/1527 (44.8)

70/175 (40.0)

2423/5778 (41.9)

College degree or higher

479/1527 (31.4)

15/175 (8.6)

1290/5778 (22.3)

≤$1,600

1170/1467 (79.8)

162/175 (92.6)

4574/5707 (80.1)

>$1,600

297/1467 (20.2)

13/175 (7.4)

1133/5707 (19.9)

No

1218 (79.8)

106 (60.2)

3468 (60.0)

Yes

309 (20.2)

70 (39.8)

2313 (40.0)

No

969 (63.5)

79 (44.9)

3522 (60.9)

Yes

558 (36.5)

97 (55.1)

2259 (39.1)

Characteristic
Age — yr
Race — no./total no. (%)†

Educational level — no./total no. (%)‡

Monthly income — no./total no. (%)§

Receiving public assistance — no. (%)¶

Trouble paying basic expenses — no. (%)‖

Health insurance — no./total no. (%)**
None

631/1507 (41.9)

102/176 (58.0)

2304/5748 (40.1)

Private

796/1507 (52.8)

55/176 (31.3)

2438/5748 (42.4)

Public

80/1507 (5.3)

19/176 (10.8)

1006/5748 (17.5)

0

1088 (71.3)

90 (51.1)

2384 (41.2)

Parity — no. (%)

2000

1

279 (18.3)

34 (19.3)

1530 (26.5)

2

115 (7.5)

32 (18.2)

1152 (19.9)

≥3

45 (2.9)

20 (11.4)

715 (12.4)

n engl j med 366;21
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Table 1. (Continued.)
PPR
(N = 1527)

DMPA
(N = 176)

LARC
(N = 5781)

0

829/1522 (54.5)

61/176 (34.7)

1839/5770 (31.9)

Characteristic
Previous unintended pregnancies — no./
total no. (%)††
1

393/1522 (25.8)

44/176 (25.0)

1566/5770 (27.1)

2

159/1522 (10.4)

36/176 (20.5)

1064/5770 (18.4)

≥3

141/1522 (9.3)

35/176 (19.9)

1301/5770 (22.5)

0

1072 (70.2)

106 (60.2)

3672 (63.5)

1

331 (21.7)

41 (23.3)

1294 (22.4)

2

87 (5.7)

21 (11.9)

530 (9.2)

≥3

37 (2.4)

8 (4.5)

285 (4.9)

No

1008 (66.0)

90 (51.1)

3397 (58.8)

Yes

519 (34.0)

86 (48.9)

2384 (41.2)

Previous abortions — no. (%)

History of STI — no. (%)‡‡

* Plus–minus values are means (±SD). P<0.001 for comparisons of the three groups. The total number of participants
does not equal 7486 because 2 participants chose natural family planning as their contraceptive method at baseline
but then went on to choose another method later in the study. Percentages may not necessarily add up to 100 because of rounding. DMPA denotes depot medroxyprogesterone acetate; LARC long-acting reversible contraception
(intrauterine device or implant); PPR pill, patch, or ring; and STI sexually transmitted infection.
† Race was self-reported. Data were missing for 8 participants in the PPR group and 31 in the LARC group.
‡ Data on educational level were missing for 1 participant in the DMPA group and 3 in the LARC group.
§ Data on monthly income were missing for 60 participants in the PPR group, 1 in the DMPA group, and 74 in the
LARC group.
¶		 “Receiving public assistance” was defined as self-reported current receipt of food stamps; vouchers from the supplementary nutritional program for women, infants, and children (WIC); welfare; or unemployment benefits.
‖ “Trouble paying basic expenses” was defined as self-reported difficulty in paying for transportation, housing, health or
medical care, or food.
** Data on health insurance were missing for 20 participants in the PPR group and 33 in the LARC group.
†† Data on previous unintended pregnancies were missing for 5 participants in the PPR group and 11 in the LARC group.
‡‡ Data are based on a self-reported history of chlamydia infection, gonorrhea, syphilis, trichomoniasis, genital herpes,
human papillomavirus infection, or human immunodeficiency virus infection.

Information about periods of contraceptive
use, including start and stop dates, was collected
from three sources: scheduled telephone interviews; pharmacy data obtained from the partner
pharmacy where participants obtained pills,
patch, or ring; and the participant contraceptivemethod log, which documented in our research
records when the participant initiated or discontinued use of a method or switched to another
method (i.e., insertion or removal of an IUD or
implant; receipt of an initial pill supply, patch,
or ring; and DMPA injection). A participant was
considered to have used DMPA for the 3-month
interval after a record of an injection. In the case
of expulsion of an IUD, if the participant knew
the device had fallen out and she became pregnant, the unintended pregnancy was attributed
to “no method” (unless an alternative method
n engl j med 366;21

was used). However, if the participant was unaware that the device had fallen out, the pregnancy was attributed to IUD failure.
At each follow-up interview, we asked participants if they were still using the same contraceptive method, if they had stopped using it, and
their start and stop dates. For participants who
did not answer these questions, we reviewed
their contraceptive-method log and pharmacyrefill records to confirm their status. If the data
from the log, follow-up interview, and pharmacy
records were conflicting, we used the data source
with the most detailed information. If multiple
contraceptive methods were used simultaneously
(e.g., pills and condoms), the most effective method was assigned.9 Data from participants who
were lost to follow-up were censored at the time
of their last completed interview.
nejm.org
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STUDY OUTCOMES

The primary outcome of the study was contraceptive failure. We also evaluated pregnancy rates by
age group as a secondary outcome. Our hypotheses were, first, that participants using pills, patch,
or ring would have higher rates of contraceptive
failure than those using long-acting methods
and, second, that the rate of failure with the pills,
patch, or ring would be higher among younger
women and adolescents (<21 years of age) than
among older women.
STATISTICAL ANALYSIS

Statistical analyses were performed with the use
of Stata software, version 11 (StataCorp). The significance level (alpha) was set at 0.05. To describe
the demographic characteristics of the study participants, we used means, standard deviations,
frequencies, and percentages. For the comparison among users of different contraceptive methods, Student’s t-test was used for continuous
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variables and a chi-square test was performed for
categorical data.
We measured distinct segments of contraceptive-method use that represented the months each
participant used the method. We calculated participant-years of use for each method by capturing all segments of use. Thus, participants who
switched methods contributed distinct segments
to multiple methods. Cox proportional-hazard
models were used to estimate the hazard ratios
for unintended pregnancy with different methods.
We used clustering of variance–covariance estimation methods to account for the effect of correlation among different periods of contraceptive use
and multiple pregnancies for the same participant.
Effect modification was assessed by including an
interaction term between the method and the covariate of interest in the model. The final multivariate model included adjustment for confounders
and other variables with the potential to influence
the outcome.

Table 2. Baseline Characteristics of Participants with No Pregnancy and Those with an Unintended Pregnancy
during the Study Period.*
No Pregnancy
(N = 7152)

Unintended
Pregnancy
(N = 334)

P Value

25.2±5.8

23.6±5.1

<0.001

Black

3408/7113 (47.9)

200/334 (59.9)

White

3163/7113 (44.5)

104/334 (31.1)

Other

542/7113 (7.6)

30/334 (9.0)

High school or less

2356/7148 (33.0)

163/334 (48.8)

Some college

3044/7148 (42.6)

134/334 (40.1)

College degree or higher

1748/7148 (24.5)

37/334 (11.1)

Characteristic
Age — yr
Race — no./total no. (%)†

<0.001

Educational level — no./total no. (%)‡

<0.001

Monthly income — no./total no. (%)§

0.01

≤$1,600

5629/7025 (80.1)

279/326 (85.6)

>$1,600

1396/7025 (19.9)

47/326 (14.4)

No

4606 (64.4)

187 (56.0)

Yes

2546 (35.6)

147 (44.0)

Receiving public assistance — no. (%)

0.002

Trouble paying basic expenses — no. (%)

<0.001

No

4409 (61.6)

162 (48.5)

Yes

2743 (38.4)

172 (51.5)

None

2872/7102 (40.4)

165/331 (49.8)

Private

3179/7102 (44.8)

111/331 (33.5)

Public

1051/7102 (14.8)

55/331 (16.6)

Health insurance — no./total no. (%)¶

2002

n engl j med 366;21
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Table 2. (Continued.)
No Pregnancy
(N = 7152)

Characteristic

Unintended
Pregnancy
(N = 334)

Parity — no. (%)

P Value
0.002

0

3436 (48.0)

127 (38.0)

1

1738 (24.3)

106 (31.7)

2

1239 (17.3)

60 (18.0)

≥3

739 (10.3)

41 (12.3)

Previous unintended pregnancies — no./
total no. (%)‖

<0.001

0

2664/7137 (37.3)

66/333 (19.8)

1

1896/7137 (26.6)

107/333 (32.1)

2

1195/7137 (16.7)

64/333 (19.2)

≥3

1382/7137 (19.4)

96/333 (28.8)

Previous abortions — no. (%)

<0.001

0

4661 (65.2)

190 (56.9)

1

1584 (22.1)

82 (24.6)

2

592 (8.3)

47 (14.1)

≥3

315 (4.4)

15 (4.5)

History of STI — no. (%)

<0.001

No

4337 (60.6)

159 (47.6)

Yes

2815 (39.4)

175 (52.4)

* Plus–minus values are means (±SD). Percentages may not add up to 100 because of rounding.
† Data on race were missing for 39 participants in the no-pregnancy group.
‡ Data on educational level were missing for 4 participants in the no-pregnancy group.
§ Data on monthly income were missing for 127 participants in the no-pregnancy group and 8 in the unintendedpregnancy group.
¶ Data on health insurance were missing for 50 participants in the no-pregnancy group and 3 in the unintendedpregnancy group.
‖ Data on previous unintended pregnancies were missing for 15 participants in the no-pregnancy group and 1 in the
unintended-pregnancy group.

R E SULT S
CHARACTERISTICS OF THE PARTICIPANTS

From August 2007 through May 2011, a total of
8445 participants enrolled in the study, and 7486
met the eligibility criteria for this analysis. We
identified 334 unintended pregnancies; of these,
156 were attributed to IUD, implant, DMPA injection, pill, patch, or ring failure. Table 1 summarizes the demographic and reproductive characteristics of the participants, according to the
method of contraception chosen at baseline. Participants who chose pills, patch, or ring at enrollment, as compared with those who chose other
contraceptive methods, were more likely to be
nulliparous, more likely to have private health
insurance, and less likely to have had a previous
unintended pregnancy, abortion, or sexually transn engl j med 366;21

mitted infection. Participants who chose DMPA
injections were more likely to be black, to be less
educated, to have a lower socioeconomic status, to
have no health insurance, and to have a history
of a sexually transmitted infection. Participants
who chose an IUD or implant were more likely to
be older, to have public health insurance, and to
have higher parity.
Table 2 shows the baseline characteristics of
participants who had no pregnancy and those who
had an unintended pregnancy during the study
period. Participants who had an unintended pregnancy were younger, less educated, more likely to
be black, and more likely to rely on public assistance or to report difficulty paying for basic expenses. They were also more likely to have a
history of unintended pregnancy, abortion, or
sexually transmitted infection.
nejm.org

may 24, 2012

2003

The New England Journal of Medicine
Downloaded from nejm.org at WASHINGTON UNIV SCH MED MEDICAL LIB on April 29, 2014. For personal use only. No other uses without permission.
Copyright © 2012 Massachusetts Medical Society. All rights reserved.

Participants with Contraceptive Failure
(%)

The

12

LARC

DMPA

n e w e ng l a n d j o u r na l

PPR

10
8
6
4
2
0

1

2

3

Year

Figure 1. Cumulative Percentage of Participants Who Had a Contraceptive
Failure at 1, 2, or 3 Years, According to Contraceptive Method.
Bars depict the cumulative percentage of participants who had a contraceptive failure with long-acting reversible contraception (LARC), depot
medroxyprogesterone acetate (DMPA), or pill, patch, or ring (PPR) at 1, 2,
or 3 years. Participants using PPR had significantly more unintended pregnancies than those using LARC (P<0.001) or DMPA (P<0.001).

CONTRACEPTIVE FAILURE RATES

Figure 1 shows the cumulative percentage of
participants with a contraceptive failure at 1, 2,
or 3 years, according to the contraceptive method.
At all three time points, participants using pills,
patch, or ring had higher rates of unintended pregnancy than those using long-acting reversible contraception. Failure rates in the group of participants
who used the pills, patch, or ring were 4.8%, 7.8%,
and 9.4% in years 1, 2, and 3, respectively; the corresponding rates in the group using IUDs or implants were 0.3%, 0.6%, and 0.9% (P<0.001). The
failure rates among participants who used DMPA
injections were similar to those among participants
who used IUDs or implants (0.1%, 0.7%, and 0.7%
for years 1, 2, and 3, respectively; P = 0.96).
Table 3 shows the risks of contraceptive failure
associated with the chosen contraceptive methods and other characteristics of the participants.
The failure rate for the pills, patch, or ring was
4.55 per 100 participant-years, as compared with
0.22 for DMPA injections and 0.27 for IUDs or
implants (P<0.001 for both comparisons). The
risk of unintended pregnancy among participants
using pills, patch, or ring was markedly higher
than that among participants who used longacting reversible contraception (hazard ratio after
adjustment for age, educational level, and number
of previous unintended pregnancies, 21.8; 95%
confidence interval [CI], 13.7 to 34.9).
2004

n engl j med 366;21
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To determine whether participants less than
21 years of age who used pills, patch, or ring had
a higher rate of unintended pregnancy than older
women using these methods, we stratified our
sample according to age. Participants less than
21 years of age who were using pills, patch, or ring
had almost twice the risk of unintended pregnancy
as older women (hazard ratio after adjustment for
educational level and history with respect to unintended pregnancy, 1.9; 95% CI, 1.2 to 2.8) (Fig. 2).
The rate of contraceptive failure did not differ significantly according to age group among participants who used DMPA injections or among those
who used long-acting reversible contraception, but
numbers for these analyses were smaller and the
power to detect differences was low.

DISCUSSION
We found that participants using oral contraceptive pills, a transdermal patch, or a vaginal ring had
a risk of contraceptive failure that was 20 times
as high as the risk among those using long-acting
reversible contraception. The failure rate among
participants who used pills, patch, or ring was
4.55 per 100 participant-years, as compared with
0.22 for those who used DMPA and 0.27 for those
who used an IUD or implant. Participants less than
21 years of age who used pills, patch, or ring had
almost twice the risk of unintended pregnancy as
older women using the same methods.
Our findings on contraceptive-method effectiveness are supported by previous studies. The
National Survey of Family Growth estimates that
9% of women using oral contraceptive pills will
have an unintended pregnancy within the first
year, as compared with only 0.001%, 0.14%, and
0.7% of women who use the subdermal implant,
levonorgestrel IUD, or copper IUD, respectively.8
However, these data were derived from retrospective surveys that asked women to recall their contraceptive use and pregnancies over the past (on
average) 3.75 years.4,8 The failure rate for DMPA
injections in our study is lower than other reported rates because we categorized a pregnancy
as a contraceptive failure only in users who had
returned for injections; thus, these rates represent “perfect use” rather than typical use, given
that more than 40% of women who use DMPA
will discontinue use in the first year.10
Half of all pregnancies in the United States
are unintended, and half of those result from connejm.org
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Table 3. Hazard Ratio for Unintended Pregnancy, According to Contraceptive Method and Selected Characteristic.

Variable

Unintended
Pregnancy
(N = 156)*

Total ParticipantYears

Incidence

Hazard Ratio (95% CI)†
Unadjusted

Adjusted

no./100 participantyears

no.
Contraceptive method
LARC

21

7655

0.27

1.00

1.00

DMPA

2

902

0.22

0.72 (0.17–3.09)

0.70 (0.16–3.03)

133

2924

4.55

16.05 (10.19–25.29)

21.84 (13.67–34.88)

PPR
Age
<21 yr

1.83 (1.25–2.69)

≥21 yr

1.00

Educational level
High school or less

1.00

Some college

0.73 (0.52–1.03)

College degree or higher

0.49 (0.28–0.87)

Previous unintended pregnancies
0

1.00

1

3.22 (1.99–5.19)

2

3.95 (2.29–6.81)

≥3

5.77 (3.40–9.81)

* The remaining 178 of the 334 unintended pregnancies were attributed to failure of condoms, withdrawal, or any form of contraception that
was not included in this analysis. Only periods of index contraceptive-method use (pills, patch, ring, DMPA injection, implant, or intrauterine device) and associated pregnancies were included in this analysis.
† Hazard ratios were adjusted for age, educational level, and number of previous unintended pregnancies.

traceptive failure.1,4 Among women using reversible contraception, 70% use pills or condoms,7 and
one in every eight users of reversible methods will
have a contraceptive failure in the first year.4 We
have previously shown in the same cohort that
participants using long-acting reversible methods
of contraception have higher continuation rates
(>80%) at 12 months than participants using
other reversible methods (range, 49 to 57%).10 If
more women used the highly effective, longacting reversible methods, we would expect a
decrease in the number of unintended pregnancies, because there would be more women continuing to use contraception.14
There are few contraindications to long-acting
reversible contraception; almost all women are
eligible for an IUD or implant. The U.S. Medical
Eligibility Criteria for Contraceptive Use provides
guidelines from the Centers for Disease Control
and Prevention that are endorsed by the American

n engl j med 366;21

College of Obstetricians and Gynecologists.15
Modern IUDs do not carry an increased risk of
pelvic inflammatory disease after the first 20 days
following insertion.16 Women who are at average
risk for sexually transmitted infections are good
candidates for IUDs, as long as they do not have
cervicitis at the time of insertion.15 IUDs and implants are also associated with acceptable adverseevent rates among adolescents and nulliparous
women; satisfaction rates among adolescents and
young women using the levonorgestrel IUD or
the implant are similar to the rates among older
women.10,11,17 Implants also have very few contraindications. Unpredictable bleeding is the most
common side effect and the most frequent reason for discontinuation.18
In our age-stratified analysis, participants less
than 21 years of age who used pills, patch, or
ring had a significantly increased risk of contraceptive failure, as compared with older women; in
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Probability of Not Having an
Unintended Pregnancy
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Figure 2. Probability of Not Having an Unintended Pregnancy, According to
Contraceptive Method and Age.
Survival curves show the probability of not having an unintended pregnancy, stratified according to age group. LARC methods were the most effective, and failure rates did not vary according to age (P = 0.49). PPR methods
were less effective, and failure rates in participants younger than 21 years
old were twice as great as in women 21 years of age or older (P = 0.02).

contrast, younger and older participants who
used an IUD, implant, or DMPA had similarly low
risks of pregnancy. Other study data have also indicated that the risk of contraceptive failure with
pills is more than twice as high among teenagers
as it is among women older than 30 years of age.4
The increased risk of contraceptive failure among
adolescents, as compared with women, may reflect
lower adherence to a daily pill regimen. In a sample of girls who were 14 to 17 years of age and
who were seeking primary care, 25% of those who
used oral contraceptive pills reported that they
missed taking two or more pills per cycle.19 These
data underscore the potential benefits of offering
adolescents long-acting reversible contraception
(which does not require daily, weekly, or monthly
compliance) to reduce unintended pregnancies in
this high-risk age group.
The strengths of our study include the prospective design of the Contraceptive CHOICE Project,
a large sample, multiple sources of data for as-

of

m e dic i n e

sessment of contraceptive use (including objective
pharmacy data), and a low rate of loss to follow-up.
There are few prospective reports in the medical
literature that assess the effectiveness of contraceptive methods in large, diverse U.S. populations.
One limitation of our study is the nonrandomized design, resulting in potential confounding
of the association between contraceptive method
and outcomes by characteristics associated with
the choice of contraception. However, women
who chose long-acting methods tended to be
less educated and to have higher rates of previous pregnancies and abortions — features expected to be associated with higher (not lower)
rates of unintended pregnancy. In addition, study
participants were a selected group (at high risk
for unintended pregnancy and willing to begin
using a new method). Insofar as women may be
more likely to consistently use a method they
have chosen than one they have been assigned,
the compliance rates may be higher, and failure
rates lower, than would be expected in a randomized trial. Another potential limitation of our
study is generalizability. Participants were at high
risk for unintended pregnancy and had to be willing to switch to a new contraceptive method,
which may have resulted in overestimation of contraceptive failure rates, as compared with rates in
the general U.S. population. However, contraception was provided at no cost, which may have improved adherence and led to an underestimation of
failure rates, counterbalancing this potential bias.
In conclusion, we found that long-acting reversible methods of contraception (IUDs or implants)
were more effective in preventing unintended pregnancy than contraceptive pills, patch, or ring and
worked well regardless of age.
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